prognostic

Related by string. Prognostic * * prognostic significance . prognostic markers . unfavorable prognostic . prognostic factors . prognostic factor . prognostic marker . prognostic indicator . prognostic indicators . diagnostic prognostic . diagnostics prognostics . prognostic biomarkers . prognostic variables . prognostic biomarker . Evidence Prognostic Level . Prognostic Factors *

Related by context. All words. (Click for frequent words.) 65 risk stratification 65 biomarker 65 prognostic marker 64 FDG PET 64 predictive 63 prognostic significance 63 predictive biomarker 63 stratify patients 63 KRAS mutation status 62 Prognostic 62 prognostic factor 62 prognostic indicator 62 prognostic markers 61 prognostic indicators 61 biomarkers 59 genetic polymorphisms 59 prognostic factors 59 prognostic biomarker 58 prognostic variables 57 FDG-PET/CT 57 genomewide 57 sensitivity specificity 57 biochemical recurrence 57 PITX2 57 immunohistochemical 57 microsatellite instability 57 stratifying patients 56 surrogate marker 56 nomogram 56 distant metastasis 56 PCa 56 univariate 56 F FDG PET 56 lymph node metastasis 56 PROLARIS 56 KRAS mutation 56 D dimer 56 PITX2 methylation 56 ERCC1 56 subclinical atherosclerosis 56 NT proBNP 55 prostate cancer CaP 55 PSA velocity 55 HNSCC 55 breast carcinoma 55 multivariate Cox 55 NGAL 55 adjuvant chemotherapy 55 HERmark 55 estrogen receptor ER 55 neoadjuvant chemotherapy 55 prognostic biomarkers 55 Recurrence Score 55 stratify 55 diagnostic prognostic 55 stratifying 55 micrometastasis 55 #F FDG PET 54 ChemoFx ® 54 clinicopathological 54 LV dysfunction 54 progesterone receptor PR 54 Framingham Risk Score 54 Oncotype DX Recurrence Score 54 histologic 54 PSADT 54 comorbidity 54 PCA3 54 gene expression profiling 54 prostate cancer PCa 54 EUS FNA 54 MDRD equation 54 postoperative radiotherapy 54 galectin 3 54 gated SPECT 54 myocardial perfusion 54 prognostically 54 protein biomarkers 54 lymph node involvement 54 histopathologic 54 CaP 54 PD2i ® 54 perfusion imaging 54 Coronary artery calcium 54 HER2 overexpression 54 hepatocellular carcinoma 54 adjuvant radiotherapy 54 pancreatic adenocarcinoma 54 HER2 53 pathologic 53 T1a 53 immunohistochemical staining 53 morphologic 53 electron beam computed tomography 53 coronary artery calcium 53 diagnostic 53 epithelial tumors 53 Epigenomics proprietary 53 Prognostic factors 53 pelvic lymphadenectomy 53 EQ 5D 53 MammaPrint R 53 clusterin 53 urothelial carcinoma 53 Lp PLA2 53 adjuvant therapy 53 oncologic outcomes 53 Oncotype DX 53 sentinel lymph node biopsy 53 troponins 53 MR spectroscopy 53 preoperative staging 53 genetic biomarkers 53 KRAS status 53 malignant nodules 53 coronary angiography 53 Lymph node 53 rs# [002] 53 microalbuminuria 53 liver fibrosis 53 multivariate analyzes 53 VeriStrat 53 APTIMA HPV 53 pCR 53 renal tumors 53 gastric carcinoma 53 neoadjuvant 53 Cystatin C 53 HER2 expression 53 lymphadenectomy 52 TOP2A 52 logistic regression 52 operable breast cancer 52 hepatic fibrosis 52 adjuvant therapies 52 cardiac troponin 52 univariate analysis 52 EGFR mutation status 52 histopathological 52 antigen PSA 52 NADiA TM 52 prostate carcinoma 52 distant metastases 52 carotid IMT 52 mRCC 52 hsCRP 52 clinically localized prostate 52 lymph node metastases 52 plain radiographs 52 HER-2/neu 52 Logistic regression 52 nomograms 52 Subgroup analyzes 52 binary logistic regression 52 gene polymorphisms 52 NPRL2 52 IL#B 52 interobserver agreement 52 thyroglobulin 52 diagnose Alzheimer disease 52 ERBB2 52 metastatic renal cell carcinoma 52 penetrance 52 pharmacogenetic 52 bone scintigraphy 52 nodal metastases 52 cystatin C 52 cTnI 52 PET imaging 52 K ras mutation 52 etiologic 52 echocardiographic 52 myocardial viability 52 locoregional recurrence 52 obstructive coronary artery 52 K ras mutations 52 Kaplan Meier analysis 52 Fractional Flow Reserve 52 echocardiographic parameters 51 peritoneal carcinomatosis 51 preoperative diagnosis 51 noninvasive imaging 51 HAAH 51 Clusterin 51 preoperative PSA 51 imaging modality 51 molecular biomarker 51 molecular biomarkers 51 bladder carcinoma 51 KRAS variant 51 GSTP1 51 BRAF mutation 51 haematopoietic 51 transient elastography 51 #F FDG 51 multivariate logistic regression 51 apolipoproteins 51 hepatic lesions 51 SLN biopsy 51 Preoperative 51 Radical prostatectomy 51 prostate carcinogenesis 51 sCJD 51 mammographic density 51 tumor histology 51 surrogate markers 51 molecular markers 51 myocardial ischemia 51 diagnostic biomarker 51 Prostate specific antigen 51 stress echocardiography 51 nonparametric 51 pT2 51 nephron sparing surgery 51 chemosensitivity 51 anti JCV antibodies 51 HRQOL 51 Multiple logistic regression 51 Immunohistochemistry IHC 51 carotid bruit 51 breast cancer subtypes 51 NPM1 mutation 51 colorectal cancer CRC 51 hemodynamic 51 lobular carcinoma 51 HER2 positive cancers 51 situ LCIS 51 HER2 negative 51 platelet reactivity 51 serum biomarker 51 immunohistochemical analysis 51 immunohistochemistry 51 genomic alterations 51 breast cancer metastasis 51 clinico pathological 51 transcriptomic 51 neoadjuvant therapy 51 DNA methylation biomarker 51 preoperative chemotherapy 51 Prostate Px + 51 EGFR TKIs 51 soluble CD# ligand 51 tumor hypoxia 51 endophenotypes 51 COR Analyzer 51 KRAS mutations 51 taxane therapy 51 Genentech Tarceva 51 coronary stenosis 51 chemoprevention 51 cCTA 51 miRview mets 51 cytogenetic 51 MSCT 51 FDG PET CT 51 CYP#C# [001] 51 potentially modifiable 50 VerifyNow P#Y# 50 clinicopathological features 50 univariate analyzes 50 diagnostic modality 50 CSF biomarkers 50 waist circumference WC 50 pharmacodynamic PD 50 epithelial ovarian cancer 50 ASCUS 50 micrometastases 50 EGFR mutation positive 50 logistic regression analysis 50 CTEPH 50 immunochemical fecal occult 50 SLNB 50 seminal vesicle invasion 50 multivariable analysis 50 locoregional 50 PSA kinetics 50 DNA methylation patterns 50 PNH patients 50 liver metastasis 50 carcinoembryonic antigen 50 miRview squamous 50 medically inoperable 50 thyroid nodules 50 QRISK 50 mucinous 50 cervical carcinoma 50 hENT1 50 NMP# 50 VKORC1 50 tumorigenicity 50 immunohistochemistry IHC 50 dyssynchrony 50 HOMA IR 50 miRview ® 50 TNM staging 50 Reynolds Risk Score 50 urine cytology 50 deCODE BreastCancer TM 50 neurocognitive function 50 obstructive CAD 50 Randomized clinical trials 50 Multivariate logistic regression 50 TGFBR1 * 6A 50 curative resection 50 perfusion CT 50 pretest probability 50 pathophysiologic 50 gefitinib Iressa 50 nodal metastasis 50 neurodevelopmental outcome 50 multivessel disease 50 coronary artery disease 50 BODE index 50 NAFLD 50 cardiac troponin T 50 PKCi 50 renal artery stenosis 50 atypia 50 EGFR tyrosine kinase inhibitors 50 node metastases 50 pretargeting 50 CHADS2 50 EGFR mutations 50 FDG uptake 50 Her2/neu 50 K ras 50 radical prostatectomy RP 50 skin sterol 50 APOE genotype 50 mutated K ras 50 MammaPrint 50 ImmuKnow 50 qRT PCR 50 BRCA mutation carriers 50 LungExpress Dx 50 independent prognostic marker 50 gene amplification 50 K RAS 50 phenotype 50 RQ PCR 50 perioperative morbidity 50 prostate biopsy 50 renal function 50 thrombophilia 50 Poisson regression 50 natriuretic peptide 50 p# biomarker 50 Haptoglobin 50 MR imaging 50 oncological outcomes 50 IPAH 50 CT angiography 50 detecting colorectal cancer 50 hematopoietic cancers 50 FDG PET imaging 50 invasive coronary angiography 50 SPECT CT imaging 50 B type natriuretic 50 endocrine therapies 50 comorbidities 50 covariate 50 multidetector row 50 FISH fluorescence 49 atherosclerotic disease 49 HSCT 49 endoglin 49 Oncotype 49 proteomic biomarkers 49 subclinical 49 clinicopathologic 49 metastatic lymph nodes 49 genotypic 49 SYNTAX trial 49 EpCAM 49 proteomic 49 lymphovascular invasion 49 pathophysiological 49 intraobserver 49 intima media thickness 49 peptide BNP 49 MiCK assay 49 T2DM 49 nonischemic 49 progesterone receptor 49 EGFR mutation 49 neratinib 49 atherothrombotic disease 49 cytologic 49 pT3 49 posttransplant 49 nonmetastatic 49 interobserver reliability 49 tumor biopsies 49 APOE e4 49 ultrasonographic 49 multivariate regression analysis 49 EpCAM expression 49 nonsmall cell lung cancer 49 molecular subtypes 49 tissue perfusion 49 HER2 positive metastatic breast 49 RASSF1A 49 incomplete revascularization 49 lipoprotein levels 49 miRview ™ squamous 49 coronary calcium 49 prostate specific 49 WT1 49 gene polymorphism 49 MGUS 49 conditional logistic regression 49 MDRD 49 colorectal adenoma 49 predictive biomarkers 49 HRQL 49 poorer prognosis 49 EBUS FNA 49 androgen deprivation 49 monoclonal gammopathy 49 serum PSA 49 promoter methylation 49 specific antigen PSA 49 ADPKD 49 chemoradiotherapy 49 chi squared 49 p tau 49 SUVmax 49 electrocardiographic 49 serous ovarian cancer 49 gastric cancer 49 prostate specific antigen 49 radiotherapy RT 49 Multivariate analysis revealed 49 Sensitivity specificity 49 rheumatoid factor 49 immunomodulation 49 Coronary CTA 49 FDG PET scans 49 prostatic adenocarcinoma 49 molecular profiling 49 Logistic regression analysis 49 SNP rs# [001] 49 pediatric malignancies 49 Charlson Comorbidity Index 49 Cardiolite ® 49 eTag assays 49 lung metastasis 49 Septin9 49 clinically relevant 49 antiangiogenic therapy 49 resected pancreatic cancer 49 atherosclerosis regression 49 Affymetrix microarray technology 49 convergent validity 49 miRview TM mets 49 BRCA2 mutation carriers 49 mammographic 49 elevated homocysteine 49 KRAS oncogene 49 ABCB1 49 MGMT gene 49 bivariate 49 pathophysiological mechanisms 49 histological subtype 49 β amyloid 49 VEGF expression 49 echocardiography 49 catheter angiography 49 BRCA carriers 49 rs# [001] 49 rs# [004] 49 esophageal carcinoma 49 lactate dehydrogenase LDH 49 hepatocellular carcinomas 49 completely resected 49 acute coronary syndromes 49 semiquantitative 49 eGFR 49 TroVax ® 49 EGFR 49 NMIBC 49 multigene expression test 49 angiographically 49 carotid stenosis 49 Lenalidomide 49 troponin T 49 biologic plausibility 49 microRNA expression 49 tHcy 49 RRM1 49 differential diagnosis 49 chromosomal mutations 49 macroalbuminuria 49 extracapsular extension 49 tumor recurrence 49 hypercholesterolemia 49 radical cystectomy 49 Multivariate analysis 49 troponin 49 adenomatous polyps 49 CT colonography 49 CIN2 + 49 Fc gamma receptor 49 Liver biopsy 49 GRNCM1 49 colorectal cancer 49 radical prostatectomy 49 pharmacologic 49 neuropathological 49 multivariable Cox 49 aMCI 49 CC genotype 49 diffuse gastric 49 quantitative RT PCR 49 histology 49 myeloperoxidase 49 cirrhotic patients 49 CTNNB1 49 interobserver 49 lymph node dissection 49 metabolic parameters 49 immunochemical 49 antiplatelet therapy 49 logistic regression model 49 multislice CT 49 antiangiogenic agent 48 aetiology 48 Troponin 48 coronary angiogram 48 PCA3 assay 48 autonomic dysfunction 48 NSCLC tumors 48 sonographic findings 48 mutational status 48 undergoing coronary angiography 48 Oncotype DX colon cancer 48 axillary dissection 48 surrogate endpoint 48 OncotypeDX 48 carotid intima media 48 BRCA1 mutations 48 FFR measurements 48 fibrosis 48 PD2i R 48 splice variant 48 PCA3 gene 48 prognosis 48 adjuvant radiation 48 mTOR inhibitors 48 MetS 48 BI RADS 48 mechanistic insights 48 sonographic 48 cystatin 48 familial predisposition 48 HNPCC 48 ventricular dysfunction 48 MSH2 48 axillary lymph node 48 endothelial activation 48 TCF#L# 48 #.#ng/ml 48 elevated CRP 48 cerebral oximetry 48 Kaplan Meier 48 quantitative gene expression 48 xenograft models 48 pharmacodynamic biomarkers 48 etiological 48 presymptomatic 48 T2D 48 quantification 48 breast carcinomas 48 colorectal liver metastases 48 pharmacogenetic testing 48 ErbB2 positive 48 contrast echocardiography 48 MYCN amplification 48 thickness IMT 48 HOXB# 48 Glomerular filtration rate 48 autoantibody 48 predictive validity 48 gene expression profiles 48 SPECT imaging 48 cardiac perfusion 48 Hsp# inhibition 48 neuroprotection 48 polymorphisms 48 indolent lymphomas 48 genomic 48 ischemic penumbra 48 adrenalectomy 48 pulmonary nodules 48 hormone receptor status 48 laterality 48 neovascular 48 putative biomarkers 48 kidney allograft 48 gadolinium enhanced 48 coronary CTA 48 differentiated thyroid 48 estrogen receptor 48 FLT3 48 hyperglycaemia 48 colorectal neoplasia 48 proteomic analysis 48 IFRD1 48 EBRT 48 abnormal glucose metabolism 48 myocardial necrosis 48 advanced adenoma 48 multivariable logistic regression 48 KRAS 48 intact parathyroid hormone 48 nonpharmacologic 48 immunostaining 48 transvaginal sonography 48 cytogenetics 48 APOC3 48 Elastography 48 HER3 48 PTPN# 48 precursor lesions 48 Immunohistochemical staining 48 DSM IV diagnoses 48 Prognostic Value 48 HGPIN 48 S#A# [002] 48 lipid abnormalities 48 antitumor effect 48 SNP rs# [002] 48 B7 H3 48 advanced neoplasia 48 biomarker assays 48 Subgroup analysis 48 cardiotoxicity 48 coronary CT angiography 48 Adjuvant chemotherapy 48 Mantle Cell Lymphoma 48 BRAF V#E mutation 48 varespladib 48 Hurthle cell 48 non squamous histology 48 QoL 48 vimentin 48 debulking surgery 48 MMSE score 48 Circulating tumor cells 48 biopsy Gleason 48 radical nephrectomy 48 cytological 48 DNA methylation markers 48 MAGE A3 48 gene variants 48 trastuzumab 48 Garcia Manero 48 resectable 48 telomerase activation 48 serum thyroglobulin 48 scintigraphy 48 HER2 gene 48 underlying pathophysiology 48 STRIDE PD 48 estrogen receptor negative 48 fine needle aspiration 48 quantitative PCR 48 ovarian carcinoma 48 carcinoid tumors 48 cardiac magnetic resonance 48 adverse cytogenetics 48 urothelial bladder cancer 48 metabolomic profiling 48 MTWA 48 contralateral breast 48 microRNA biomarkers 48 conventional angiography 48 sDNA 48 bevacizumab Avastin 48 logistic regression models 48 anti fibrotic 48 BRCA2 carriers 48 vasculopathy 48 serum albumin 48 angiography CCTA 48 methylation markers 48 thymoma 48 ischemic lesions 48 abnormal glucose tolerance 48 genomewide association studies 48 PGxPredict 48 serologic 48 HER2 neu 48 serum biomarkers 48 HERmark assay 48 diabetes mellitus DM 48 miRNA biomarkers 48 TRUS 48 Corus CAD 48 Raf MEK ERK 48 colorectal polyps 48 SPECT 48 graft patency 48 MTHFR 48 myocardial perfusion imaging 48 PALB2 48 BioMAP 48 bronchopulmonary dysplasia BPD 48 pharmacologic intervention 48 inotropic 47 kinase inhibition 47 treat NNT 47 colonoscopic 47 T1c 47 malignant lesions 47 receptor subtypes 47 HER2 positive 47 EGFR expression 47 multivariable adjusted 47 Surgical resection 47 liver histology 47 pelvic ultrasound 47 gastric atrophy 47 PHQ 9 47 scintigraphic 47 mRNA expression 47 advanced adenomas 47 residual confounding 47 p# INK4a 47 LVNC 47 albumin excretion rate 47 tumor subtypes 47 comorbid diagnoses 47 neoplastic 47 #p# [001] 47 logistic regression analyzes 47 phenotypes 47 Stat5 47 chemoresistant 47 CYP#D# genotype 47 karyotyping 47 pathogenetic 47 radiographic outcomes 47 CaPSURE 47 relapsed SCLC 47 molecular assays 47 familial pancreatic cancer 47 Leydig cell 47 UGT#A# 47 murine models 47 Histological 47 temsirolimus 47 SYNTAX 47 Univariate 47 Lp PLA 2 47 hormone refractory 47 pancreatic 47 atypical hyperplasia 47 subclinical hypothyroidism 47 AtherOx 47 electrocardiography ECG 47 PTEN gene 47 biochemical markers 47 peripheral insulin sensitivity 47 spiral computed tomography 47 Prostate Cancer Progression 47 coinfected patients 47 diagnosing coronary artery 47 vertebral fracture 47 single nucleotide polymorphism 47 endocrine therapy 47 stage IIIA 47 genomic biomarker 47 Prenatal diagnosis 47 invasive lobular carcinoma 47 retest reliability 47 TMPRSS2 ERG fusion 47 CYP#D# 47 intravesical therapy 47 pharmacokinetic PK 47 gene expression biomarkers 47 glycoprotein IIb IIIa inhibitors 47 curative therapy 47 PARP inhibition 47 Montgomery Åsberg Depression 47 HRCT 47 endothelial dysfunction 47 remnant lipoproteins 47 helical CT 47 pharmacogenetic tests 47 squamous 47 co morbidities 47 TIMP 1 47 PlGF 47 invasive carcinoma 47 quantitate 47 OVA1 47 histological subtypes 47 susceptibility locus 47 SELDI TOF 47 estrogen receptor positive 47 CEACAM1 47 cardiac biomarkers 47 castration resistant prostate cancer 47 genetic markers 47 Epidermal Growth Factor Receptor 47 nesiritide 47 amnestic MCI 47 ALSFRS R 47 Hemoglobin A1c 47 RECIST Response Evaluation Criteria 47 ADRB2 47 oral Xeloda 47 metastatic RCC 47 cardiovascular mortality 47 diabetic kidney 47 ABL1 47 cardiovascular morbidity 47 neoplasms 47 gastric adenocarcinoma 47 Ceflatonin 47 HRQoL 47 CK MB 47 spirometric 47 TAXUS Express Stent 47 eNO 47 hamartomas 47 hepatic metastases 47 genomic biomarkers 47 gemcitabine Gemzar 47 genetic variants associated 47 inflammatory biomarkers 47 pretransplant 47 situ hybridization 47 trabectedin 47 XELOX 47 HG PIN 47 idiopathic myelofibrosis 47 Bonferroni correction 47 IGF IR 47 NPM1 47 mediastinoscopy 47 histopathologic examination 47 invasive bladder 47 transabdominal 47 miRNA expression 47 dichotomized 47 ependymoma 47 gene expression 47 differentiate squamous 47 postoperative mortality 47 autoimmune pancreatitis 47 nonalcoholic steatohepatitis NASH 47 adenomatous 47 tumor angiogenesis 47 LVEF 47 coronary artery stenosis 47 psychometric properties 47 BRCA mutations 47 nested PCR 47 B7 H4 47 ADAS Cog 47 Mammostrat 47 retrospectively analyzed 47 SORL1 gene 47 prospectively defined 47 stenoses 47 ZNF# 47 resected 47 ADVEXIN therapy 47 conventional coronary angiography 47 cTnT 47 breast tumors 47 Prostate Specific Antigen PSA 47 multimodality 47 Getzenberg 47 thiopurine 47 fluorodeoxyglucose positron emission tomography 47 pancreatic lung 47 antiplatelet agents 47 neoadjuvant treatment 47 cardiac dysfunction 47 cerebral perfusion 47 Octreolin 47 perfusion abnormalities 47 MLH1 47 histologies 47 NIHSS 47 fluoropyrimidine 47 estimated GFR 47 VeraTag 47 tumor resection 47 LQTS 47 tumor lysis syndrome 47 NIHSS score 47 autologous transplantation 47 Hyperlipidemia 47 ESR1 47 clinically meaningful 47 cytogenic 47 lupus anticoagulant 47 poly ADP ribose polymerase 47 Computed tomography 47 aneuploidy 47 cardiac allograft vasculopathy 47 brain natriuretic peptide 47 pro angiogenic 47 underwent coronary angiography 47 fulvestrant 47 MDCT 47 Genomic Grade 47 arteriography 47 platelet function 47 beta blocker therapy 47 histologic diagnosis 47 attenuation correction 47 CTAP# Capsules 47 localized renal 47 vivo 47 pathologic diagnosis 47 biodistribution 47 radioiodine therapy 47 BREVAGen ™ 47 SPECT MPI 47 albuminuria 47 antiangiogenic agents 47 gastric carcinomas 47 comorbid conditions 47 Doxil ® 47 histological diagnosis 47 mediated immunity 47 elacytarabine 47 Myocardial Infarction 47 warfarin dosing 47 ECOG 47 gene loci 47 multiplex PCR 47 adolescent idiopathic scoliosis 47 DXA 47 renal dysfunction 47 aortic stiffness 47 metabolic syndrome MetS 47 SF #v# 47 intracoronary 47 familial hypercholesterolemia 47 methylation patterns 47 guaiac 47 2 diabetes T2D 47 dopaminergic neuron 47 proportional hazards 47 myocardial infarction 47 carotid atherosclerosis 47 T1DM 47 urolithiasis 47 malignant transformation 47 pulmonary metastases 47 Oncotype DX breast cancer 47 glycosylated hemoglobin levels 47 TRAS 47 cytoreductive nephrectomy 47 warfarin dose 47 DEXA scan 47 invasive carcinomas 47 TIMP 47 liver biopsy 47 extracolonic 46 chronic pancreatitis 46 urine dipstick 46 lipid profiles 46 C reactive protein 46 dysbindin 46 LHRH receptor positive 46 Li Fraumeni 46 linkage disequilibrium 46 glomerular filtration rate 46 dimensional echocardiography 46 diabetic nephropathy 46 effector function 46 rhIGF 46 NSCLC 46 carcinoid 46 transthoracic 46 thyroid stimulating hormone 46 FCGR3A 46 plasma lipid 46 PD2i 46 deCODE AF TM 46 thromboembolic disease 46 secretin 46 statin therapy 46 cytogenetic abnormalities 46 reperfusion therapy 46 sonographic diagnosis 46 methylenetetrahydrofolate reductase 46 TRAF1 C5 46 adjuvant tamoxifen 46 genotype phenotype 46 nodal dissection 46 somatic mutations

Back to home page